|
1.
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2.
|
Okuda K: Hepatocellular carcinoma. J
Hepatol. 32:225–237. 2000. View Article : Google Scholar
|
|
3.
|
Llovet JM, Burroughs A and Bruix J:
Hepatocellular carcinoma. Lancet. 362:1907–1917. 2003. View Article : Google Scholar
|
|
4.
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Raza SA, Clifford GM and Franceschi S:
Worldwide variation in the relative importance of hepatitis B and
hepatitis C viruses in hepatocellular carcinoma: a systematic
review. Br J Cancer. 96:1127–1134. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Parkin DM: The global health burden of
infection-associated cancers in the year 2002. Int J Cancer.
118:3030–3044. 2006.PubMed/NCBI
|
|
7.
|
Katyal S, Oliver JR, Peterson MS, Ferris
JV, Carr BS and Baron RL: Extrahepatic metastases of hepatocellular
carcinoma. Radiology. 216:698–703. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Kummar S and Shafi NQ: Metastatic
hepatocellular carcinoma. Clin Oncol (R Coll Radiol). 15:288–294.
2003. View Article : Google Scholar
|
|
9.
|
Lopez PM, Villanueva A and Llovet JM:
Systematic review: evidence-based management of hepatocellular
carcinoma - an updated analysis of randomized controlled trials.
Aliment Pharmacol Ther. 23:1535–1547. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Belghiti J, Cortes A, Abdalla EK,
Régimbeau JM, Prakash K, Durand F, Sommacale D, Dondero F, Lesurtel
M, Sauvanet A, Farges O and Kianmanesh R: Resection prior to liver
transplantation for hepatocellular carcinoma. Ann Surg.
238:885–893. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Ikai I, Itai Y, Okita K, Omata M, Kojiro
M, Kobayashi K, Nakanuma Y, Futagawa S, Makuuchi M and Yamaoka Y:
Report of the 15th follow-up survey of primary liver cancer.
Hepatol Res. 28:21–29. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Mazzaferro V, Regalia E, Doci R, Andreola
S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A and
Gennari L: Liver transplantation for the treatment of small
hepatocellular carcinomas in patients with cirrhosis. N Engl J Med.
334:693–699. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Lai EC and Lau WY: The continuing
challenge of hepatic cancer in Asia. Surgeon. 3:210–215. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Urabe T, Kaneko S, Matsushita E, Unoura M
and Kobayashi K: Clinical pilot study of intrahepatic arterial
chemotherapy with methotrexate, 5-fluorouracil, cisplatin and
subcutaneous interferon-alpha-2b for patients with locally advanced
hepatocellular carcinoma. Oncology. 55:39–47. 1998. View Article : Google Scholar
|
|
15.
|
Zhu AX, Blaszkowsky LS, Ryan DP, Clark JW,
Muzikansky A, Horgan K, Sheehan S, Hale KE, Enzinger PC, Bhargava P
and Stuart K: Phase II study of gemcitabine and oxaliplatin in
combination with bevacizumab in patients with advanced
hepatocellular carcinoma. J Clin Oncol. 24:1898–1903. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Hotte SJ, Hirte HW, Chen EX, Siu LL, Le
LH, Corey A, Iacobucci A, MacLean M, Lo L, Fox NL and Oza AM: A
phase 1 study of mapatumumab (fully human monoclonal antibody to
TRAIL-R1) in patients with advanced solid malignancies. Clin Cancer
Res. 14:3450–3455. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Siegel AB, Cohen EI, Ocean A, Lehrer D,
Goldenberg A, Knox JJ, Chen H, Clark-Garvey S, Weinberg A, Mandeli
J, et al: Phase II trial evaluating the clinical and biologic
effects of bevacizumab in unresectable hepatocellular carcinoma. J
Clin Oncol. 26:2992–2998. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Thomas MB, Chadha R, Glover K, Wang X,
Morris J, Brown T, Rashid A, Dancey J and Abbruzzese JL: Phase 2
study of erlotinib in patients with unresectable hepatocellular
carcinoma. Cancer. 110:1059–1067. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Shirabe K, Kitamura M, Tsutsui S, Maeda T,
Matsumata T and Sugimachi K: A long-term survivor of ruptured
hepatocellular carcinoma after hepatic resection. J Gastroenterol
Hepatol. 10:351–354. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Schreibman IR, Bejarano P, Martinez EJ and
Regev A: Very late recurrence of hepatocellular carcinoma after
liver transplantation: case report and literature review.
Transplant Proc. 38:3140–3143. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Zhou XD, Tang ZY, Ma ZC, Fan J, Wu ZQ, Qin
LX, Zhou J, Yu Y, Sun HC and Qiu SJ: Twenty-year survivors after
resection for hepatocellular carcinoma-analysis of 53 cases. J
Cancer Res Clin Oncol. 135:1067–1072. 2009.PubMed/NCBI
|
